Unaudited NAV for April 2023 (1631059)
May 12 2023 - 1:00AM
UK Regulatory
Arix Bioscience PLC (ARIX) Unaudited NAV for April 2023
12-May-2023 / 07:00 GMT/BST
-----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
Unaudited NAV for April 2023
LONDON, 12 May 2023: Arix Bioscience plc ("Arix" or the
"Company") (LSE: ARIX), a transatlantic venture capital company
focused on investing in breakthrough biotechnology companies,
announces the unaudited estimated Net Asset Value ("NAV") of the
Company for the date ended 30 April 2023 as follows:
NAV Breakdown
Date Total NAV
Listed Portfolio Unlisted Portfolio Cash Other Interests NAV per share
30 April 2023
GBP58.1m GBP63.5m GBP104.2m GBP3.0m GBP228.8m GBP1.77
(unaudited)
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
+44 (0)20 7290 1050
ir@arixbioscience.com
Powerscourt Group
Sarah MacLeod, Ibrahim Khalil, Nick Johnson
+44 (0)20 7250 1446
arix@powerscourt-group.com
About Arix Bioscience plc
Arix Bioscience plc is a transatlantic venture capital company
focused on investing in breakthrough biotechnology companies around
cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the
capital, expertise, and global networks to help accelerate their
ideas into important new treatments for patients. As a listed
company, we are able to bring this exciting growth phase of our
industry to a broader range of investors.
www.arixbioscience.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: MSCL
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 243157
EQS News ID: 1631059
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1631059&application_name=news
(END) Dow Jones Newswires
May 12, 2023 02:00 ET (06:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Jan 2024 to Jan 2025